George Mason University
HHS, Cohen Foundation Award $1M to Lyme Disease Dx Research Projects
The funding is being provided to 10 groups through the LymeX Diagnostics Prize initiative, which was launched in late 2020 by theHHS- and Cohen Foundation-backed Lyme Innovation Accelerator.
Theralink Partners With George Mason, Rutgers Cancer Institute on Breast Cancer Test
The test, developed at George Mason, measures HER2 activation in a breast cancer biopsy to help determine if a patient will respond to treatment.
Fluidigm CEO Chris Linthwaite said the company aims to further penetrate the diagnostic and clinical markets with both its microfluidics and mass cytometry businesses.
Fluidigm Q4 Revenues Grow 38 Percent on COVID-19-Driven Microfluidics Growth
The firm also announced a COVID-19 testing deal with George Mason University and a CyTOF supply and distribution agreement with Zhejiang PuLuoTing Health Technology in China.
Inova, George Mason Partner to Create Proteomics Center
The partners will work together on personalized medicine research at several new centers in the Northern Virginia area.